Company: BOLT
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001193125-25-277549
Chunk: 12

Company: Bolt Biotherapeutics, Inc.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part II, Item 6
Chunk 12
---
EXHIBIT INDEX 

     Incorporated By Reference

     ExhibitNumber
      
     Description of Exhibit
      
     Form
      
     File No.
      
     Exhibit
      
     Filing Date
      
     FiledHerewith

      3.1
      
     Amended and Restated Certificate of Incorporation of the Registrant, as currently in effect. 
      
     8-K
      
     001-39988
      
     3.1
      
     2/9/2021

      3.2
      
     Certificate of Amendment to Amended and Restated Certificate of Incorporation.
      
     8-K
      
     001-39988
      
     3.1
      
     6/6/2025

      3.3
      
     Amended and Restated Bylaws of the Registrant, as currently in effect.
      
     8-K
      
     001-39988
      
     3.1
      
     4/16/2025

      4.1
      
     Reference is made to Exhibits 3.1 and 3.2.

      4.2
      
     Form of common stock certificate of the Registrant.
      
     S-1
      
     333-252136
      
     4.1
      
     1/15/2021

     31.1
      
     Certification of Principal Executive and Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     X

     32.1†
      
     Certification of Principal Executive and Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. 

     X

     101.INS
      
     Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.

     101.SCH
      
     Inline XBRL Taxonomy Extension Schema Document

     101.CAL
      
     Inline XB